Nkarta Inc. (NKTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Nkarta Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.72
+1.18% today
Market cap
$122M
Overall quality
—
Kronos AI 30-day
+58.6%
8 of 8 simulated paths end higher
Nkarta Inc. (NKTX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $122M. It trades at $1.72, up 1.18% today. 5 analysts' average target of $11.75 implies +583.1% from today's price. Kronos AI's 30-day forecast is +58.6% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $11.75 |
| Low – high | $10.00 – $14.00 |
| Analysts | 5 |
| Upside to average | +583.1% |
Kronos AI 30-day forecast
| Expected close | $2.70 (+58.6%) |
| Likely range | +54.4% … +76.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.